273 related articles for article (PubMed ID: 24923076)
21. Comparison of intra-operative 0.02% mitomycin C and sutureless limbal conjunctival autograft fixation in pterygium surgery: five-year follow-up.
Jiang J; Gong J; Li W; Hong C
Acta Ophthalmol; 2015 Nov; 93(7):e568-72. PubMed ID: 25573636
[TBL] [Abstract][Full Text] [Related]
22. Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial.
Shenasi A; Mousavi F; Shoa-Ahari S; Rahimi-Ardabili B; Fouladi RF
Cornea; 2011 Nov; 30(11):1219-22. PubMed ID: 21955635
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of limbal conjunctival autograft and low-dose mitomycin C in the treatment of recurrent pterygium.
Nabawi KS; Ghonim MA; Ali MH
Ophthalmic Surg Lasers Imaging; 2003; 34(3):193-6. PubMed ID: 12757091
[TBL] [Abstract][Full Text] [Related]
24. Subconjunctival mitomycin C as adjunctive therapy before pterygium excision.
Donnenfeld ED; Perry HD; Fromer S; Doshi S; Solomon R; Biser S
Ophthalmology; 2003 May; 110(5):1012-6. PubMed ID: 12750105
[TBL] [Abstract][Full Text] [Related]
25. Comparison of single-drop mitomycin C regime with other mitomycin C regimes in pterygium surgery.
Gupta VP; Saxena T
Indian J Ophthalmol; 2003 Mar; 51(1):59-65. PubMed ID: 12701864
[TBL] [Abstract][Full Text] [Related]
26. Combined "symmetrical conjunctival flap transposition" and intraoperative low-dose mitomycin C in the treatment of primary pterygium.
Uçakhan OO; Kanpolat A
Clin Exp Ophthalmol; 2006 Apr; 34(3):219-25. PubMed ID: 16671901
[TBL] [Abstract][Full Text] [Related]
27. Preoperative subpterygeal injection versus intraoperative mitomycin C for pterygium removal: comparison of results and complications.
Gupta VP; Gupta P; Gupta R
Am J Ophthalmol; 2011 Feb; 151(2):386-7; author reply 387-8. PubMed ID: 21251504
[No Abstract] [Full Text] [Related]
28. Combined conjunctival rotational autograft with 0.02% mitomycin C in primary pterygium surgery: a long-term follow-up study.
Tsim NC; Young AL; Jhanji V; Ho M; Cheng LL
Br J Ophthalmol; 2015 Oct; 99(10):1396-400. PubMed ID: 25837606
[TBL] [Abstract][Full Text] [Related]
29. Intraoperative application of topical mitomycin C 0.05% for pterygium surgery.
Rodriguez JA; Ferrari C; Hernández GA
Bol Asoc Med P R; 2004; 96(2):100-2. PubMed ID: 15580913
[TBL] [Abstract][Full Text] [Related]
30. Comparison of three methods for the treatment of pterygium: amniotic membrane graft, conjunctival autograft and conjunctival autograft plus mitomycin C.
Katircioğlu YA; Altiparmak UE; Duman S
Orbit; 2007 Mar; 26(1):5-13. PubMed ID: 17510864
[TBL] [Abstract][Full Text] [Related]
31. A randomised trial comparing 0.02% mitomycin C and limbal conjunctival autograft after excision of primary pterygium.
Young AL; Leung GY; Wong AK; Cheng LL; Lam DS
Br J Ophthalmol; 2004 Aug; 88(8):995-7. PubMed ID: 15258011
[TBL] [Abstract][Full Text] [Related]
32. Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study.
Lam DS; Wong AK; Fan DS; Chew S; Kwok PS; Tso MO
Ophthalmology; 1998 May; 105(5):901-4; discussion 904-5. PubMed ID: 9593395
[TBL] [Abstract][Full Text] [Related]
33. Topical application of bevacizumab as an adjunct to recurrent pterygium surgery.
Ozgurhan EB; Agca A; Kara N; Yuksel K; Demircan A; Demirok A
Cornea; 2013 Jun; 32(6):835-8. PubMed ID: 23187164
[TBL] [Abstract][Full Text] [Related]
34. [Pterygium excision using bulbar conjunctival autograft with intraoperative mitomycin C for primary pterygium: a retrospective assessment of 1832 eyes].
Masuda A; Takahashi K; Nejima R; Minami K; Miyata K
Nippon Ganka Gakkai Zasshi; 2013 Sep; 117(9):743-8. PubMed ID: 24261189
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of mitomycin C associated with direct conjunctival closure and sliding conjunctival graft for pterygium surgery.
de la Hoz F; Montero JA; Alió JL; Javaloy J; Ruiz-Moreno JM; Sala E
Br J Ophthalmol; 2008 Feb; 92(2):175-8. PubMed ID: 17962392
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of intra-operative Mitomycin-C in reducing the recurrence of pterygium in Irrua, Nigeria.
Enock ME; Omoti AE; Dawodu OA; Fuh UC; Eguaoje IE
Niger Postgrad Med J; 2010 Mar; 17(1):55-9. PubMed ID: 20348984
[TBL] [Abstract][Full Text] [Related]
37. Ten-year results of a randomized controlled trial comparing 0.02% mitomycin C and limbal conjunctival autograft in pterygium surgery.
Young AL; Ho M; Jhanji V; Cheng LL
Ophthalmology; 2013 Dec; 120(12):2390-2395. PubMed ID: 23870302
[TBL] [Abstract][Full Text] [Related]
38. Intraoperative subconjunctival bevacizumab as an adjunctive treatment in primary pterygium: a preliminary report.
Shahin MM; Elbendary AM; Elwan MM
Ophthalmic Surg Lasers Imaging; 2012; 43(6):459-66. PubMed ID: 22882007
[TBL] [Abstract][Full Text] [Related]
39. Recurrence rate of pterygium following surgical excision with intraoperative versus postoperative mitomycin-C.
Rahman A; Yahya K; Ul Hasan KS
J Coll Physicians Surg Pak; 2008 Aug; 18(8):489-92. PubMed ID: 18798585
[TBL] [Abstract][Full Text] [Related]
40. Preoperative subpterygeal mitomycin C injection.
Oğuz H
Am J Ophthalmol; 2010 Nov; 150(5):753; author reply 754. PubMed ID: 21036212
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
